日期 影响因子
日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:
–

Qualitative Exploration of the Visual Function Impairments and Health-Related Quality of Life Impacts of Amblyopia in Adult and Pediatric Populations

对成人和儿童弱视引起的视觉功能障碍及健康相关生活质量影响的定性探索

期刊:Ophthalmology and Therapy
影响因子:3.2
doi:10.1007/s40123-023-00751-8
Randhawa, Sharan; Griffiths, Natasha; O'Brien, Paul; Panter, Charlotte; Boparai, Kieran; Harrad, Richard; Khuddus, Nausheen; Webber, Ann; Bouchet, Christine; Felizzi, Federico
发表日期：2023
文献求助 收藏

The Amblyopia Quality of Life (AmbQoL): Development and Content Validation of a Novel Health-Related Quality of Life Instrument for Use in Adult and Pediatric Amblyopia Populations

弱视生活质量（AmbQoL）：一种用于成人和儿童弱视人群的新型健康相关生活质量工具的开发和内容验证

期刊:Ophthalmology and Therapy
影响因子:3.2
doi:10.1007/s40123-023-00668-2
Webber, Ann; Randhawa, Sharan; Felizzi, Federico; Soos, Mercedesz; Arbuckle, Rob; O'Brien, Paul; Harrad, Richard; Khuddus, Nausheen; Bouchet, Christine; Panter, Charlotte
发表日期：2023
文献求助 收藏

Efficacy and Safety of Brolucizumab, Aflibercept, and Ranibizumab for the Treatment of Patients with Visual Impairment Due to Diabetic Macular Oedema: A Systematic Review and Network Meta-Analysis

Brolucizumab、Aflibercept 和 Ranibizumab 治疗糖尿病性黄斑水肿引起的视力障碍患者的疗效和安全性：系统评价和网络荟萃分析

期刊:Diabetes Therapy
影响因子:2.6
doi:10.1007/s13300-023-01410-8
Sydnor, Shelby; Chatterjee, Swarnendu; Cooney, Philip; Kaur, Simarjeet; Macmillan, Tom; Stewart, Daisy; Munro, Isobel; Bandeiras, Cátia; Paine, Abby; Felizzi, Federico
糖尿病
代谢
发表日期：2023
文献求助 收藏

Approximation of Long-Term Survival with Polatuzumab Vedotin Plus Bendamustine and Rituximab for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results Based on The GO29365 Trial

波拉妥珠单抗联合苯达莫司汀和利妥昔单抗治疗复发/难治性弥漫性大B细胞淋巴瘤患者的长期生存率近似值：基于GO29365试验的结果

期刊:Pharmacoeconomics-Open
影响因子:2.1
doi:10.1007/s41669-022-00339-1
Felizzi, F; Launonen, Aino; Thuresson, P-O
淋巴瘤
细胞生物学
B细胞
免疫/内分泌
发表日期：2023
文献求助 收藏

Correction to: Approximation of Long-Term Survival with Polatuzumab Vedotin Plus Bendamustine and Rituximab for Patients with Relapsed/Refractory Diffuse Large B-Cell Lymphoma: Results Based on The GO29365 Trial

更正：Polatuzumab Vedotin联合Bendamustine和Rituximab治疗复发/难治性弥漫性大B细胞淋巴瘤患者的长期生存率估算：基于GO29365试验的结果

期刊:Pharmacoeconomics-Open
影响因子:2.1
doi:10.1007/s41669-022-00366-y
Felizzi, F; Launonen, Aino; Thuresson, P-O
淋巴瘤
细胞生物学
B细胞
免疫/内分泌
发表日期：2023
文献求助 收藏

A Social Media Listening Study to Understand the Unmet Needs and Quality of Life in Adult and Pediatric Amblyopia Patients

一项利用社交媒体监听研究来了解成人和儿童弱视患者未被满足的需求和生活质量

期刊:Ophthalmology and Therapy
影响因子:3.2
doi:10.1007/s40123-022-00571-2
Syntosi, Annie; Felizzi, Federico; Bouchet, Christine
发表日期：2022
文献求助 收藏

Mixture Cure Models in Oncology: A Tutorial and Practical Guidance

肿瘤混合治疗模型：教程与实践指南

期刊:Pharmacoeconomics-Open
影响因子:2.1
doi:10.1007/s41669-021-00260-z
Felizzi, Federico; Paracha, Noman; Pöhlmann, Johannes; Ray, Joshua
肿瘤
肿瘤免疫
发表日期：2021
文献求助 收藏

Excitotoxicity downregulates TrkB.FL signaling and upregulates the neuroprotective truncated TrkB receptors in cultured hippocampal and striatal neurons

兴奋毒性下调培养的海马和纹状体神经元中的 TrkB.FL 信号并上调具有神经保护作用的截短型 TrkB 受体

期刊:Journal of Neuroscience
影响因子:4.4
doi:10.1523/JNEUROSCI.0374-12.2012
João R Gomes, João T Costa, Carlos V Melo, Federico Felizzi, Patrícia Monteiro, Maria J Pinto, Ana R Inácio, Tadeusz Wieloch, Ramiro D Almeida, Mário Grãos, Carlos B Duarte
信号转导
神经
GPCR/Calcium/cAMP
Neuroscience
发表日期：2012
文献求助 收藏